Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma

Merkel cell carcinoma is a rare but aggressive skin cancer. Response to chemotherapy is not durable but avelumab, an anti-PD-L1 inhibitor, showed promising ongoing response in a phase II trial. Checkpoint inhibitors including avelumab are known to cause overactivation of the immune system, leading t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tun Min, Sandy, Nordman, Ina I.C., Tran, Huy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738145/
https://www.ncbi.nlm.nih.gov/pubmed/31543781
http://dx.doi.org/10.1159/000502285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738145/
https://www.ncbi.nlm.nih.gov/pubmed/31543781
http://dx.doi.org/10.1159/000502285

Ejemplares similares